Peptide Synthesis Market - Global Future Forecasts & Emerging Trends

Major Market Developments

# In 2018, CEM Corporation launched the Liberty PRIME, automated microwave peptide synthesizer.

# In 2017, Merck acquired Grzybowski Scientific Inventions (GSI) (US). This acquisition helped the company to expand its chemical synthesis portfolio.

# In 2015, Merck acquired Sigma-Aldrich Corporation (US). This acquisition strengthened Merck’s Life Science segment. Sigma-Aldrich’s SAFC Commercial business is now a part of Merck’s Life Science segment.

Target Audience:

# Biotechnology & pharmaceutical companies
# Market research and consulting firms
# Venture capitalists and investors
# Research & development companies
# Contract research organizations (CROs)
# Academic research institutes
# Government institutes

Expected Revenue Surge:

The peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365

Increasing use of peptides in pharmaceutical drugs drives the global peptide synthesis market

Peptides are highly active and highly specific drug substances. Due to the diversity of their biological functions, they are used in an extensive range of therapeutic areas. Also, they are increasingly entering drug development pathways as potential active pharmaceutical ingredients due to their large chemical space, high biological activity, high specificity, relative ease of synthesis, ready availability, and low toxicity.

Pharmaceutical & biotechnological companies are expected to dominate the peptide synthesis market in 2017

Based on end users, the peptide synthesis market is segmented into pharmaceutical & biotechnological companies, contract development and manufacturing organizations, and academic and research institutes. In 2017, pharmaceutical & biotechnological companies accounted for the largest market share due to increasing number of research projects in genomics, molecular biology, and related areas; growing application areas of peptides in drug discovery, therapeutics, and research; and substantial R&D investments.

Critical questions the report answers:

# Where will all these developments take the industry in the mid to long term?
# What are the major end users and technologies of peptide synthesis?

APAC is expected to grow at the highest CAGR during the forecast period.

Global peptide synthesis market has been studied for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in the peptide synthesis market, primarily due to the increasing investments by pharmaceutical and biotechnology companies and rising R&D activities in the region.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365

Global Leaders:

The prominent players in the peptide synthesis market are GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), Merck KGaA (Germany) and New England Peptide, Inc (US).

Product launches and agreements, partnerships and collaborations were the major strategies adopted by these payers to maintain their positions in the peptide synthesis market.